The Road Not Taken and Genomatica’s Renewable Chemicals Strategy

Genomatica, Versalis, Novamont, Industrial Biotech, Renewable Chemicals,

the biofuels sector. Just a few weeks ago, for example, J. Craig Venter declared that biofuels are dead unless the federal government adopts a carbon policy.

In developing Genomatica’s business model in 2007 and 2008, Schilling says the company chose a road that has skirted the biofuels bust. At that time, Genomatica also decided against building a commercial-scale facility and producing its own industrial chemicals from energy grasses and other sustainable raw materials.

“We were not going to be a chemical producer,” Schilling says. “We would be a chemical technology licensor,” comparable to UOP, a business now owned by Honeywell that holds thousands of patents in petrochemical cracking, processing, refining, and equipment design.

Genomatica CEO Christophe Schilling, CFO Michael Keane
Michael Keane (left) and Christophe Schilling

To advance its technology, Genomatica is looking to license its intellectual property, and the company has been forging strategic alliances with industry partners around the world. In July, for example, Genomatica signed a partnership with the Italian chemical giant Versalis and Novamont, an Italian company that specializes in making bioplastics from renewable agricultural raw materials, to produce butadiene—the raw material needed to make the synthetic rubber used in tires, footwear, and other products. “The focus really is to be the [sustainable] technology partner for the chemical industry,” Schilling says.

“What we did not know [five years ago] is that oftentimes to license technology, the licensor sometimes has to put up some capital to help build a pilot plant,” Schilling says. In another deal with Novamont, for example, Genomatica is making a

Author: Bruce V. Bigelow

In Memoriam: Our dear friend Bruce V. Bigelow passed away on June 29, 2018. He was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Bruce Bigelow joined Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University. Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.